Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats

American Journal of Veterinary Research

Volumn 61, Issue 6, 2000, Pages 672-677

  Lee, David D ^a,b   Papich, Mark G ^a   Hardie, Elizabeth M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Veterinary Specialty Hospital of the Carolinas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL CITRATE;

ANIMAL EXPERIMENT; ARTICLE; CAT; DRUG ABSORPTION; DRUG HALF LIFE; NONHUMAN; RADIOIMMUNOASSAY; SKIN ABSORPTION;

EID: 0034129409     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.672     Document Type: Article

References (27)

1. Jones RD, Baynes RE, Nimitz CT. Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990). J Am Vet Med Assoc 1992;201:475-477.
2. Mc Kellar QA, May SA, Lees P. Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: individual agents. J Small Anim Pract 1991;32:225-235.
3. Runk A, Kyles AE, Downs MO. Duodenal perforation in a cat following the administration of non-steroidal anti-inflammatory medication. J Am Anim Hosp Assoc 1999;35:52-55.
4. Principles and techniques of anesthesia and chemical restraint. In: Muir WW, Swanson CR, eds. The cat, diseases and clinical management. In: Sherding RG, ed. New York: Churchill-Livingstone Inc, 1994;91-132.
5. Jaffe JH, Martin WR. Fentanyl, opiate analgesics and antagonists. In: Goodman A, Gillman L, ed. The pharmacologic basis of therapeutics. 8th ed. Elmsford, NY: Pergamon Press Inc, 1990;494-534.
6. Yaksh TL, Noueihed RY, Durant PAC. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and the cat. Anesthesiology 1986;64:54-66.
7. Duke T, Cox AK, Remedios AM, et al. The analgesic effects of administering fentanyl or medetomidine in the lumbosacral epidural space of cats. Vet Surg 1994;23:143-148.
8. Duke T, Cox AK, Remedios AM, et. al. The cardiopulmonary effects of placing fentanyl or medetomidine in the lumbosacral epidural space of isoflurane anesthetized cats. Vet Surg 1994;23:149-155.
9. Durant PA, Yaksh TL. Epidural injections of bupivicaine, morphine, fentanyl, lofentanil, and DADL in chronically implanted rats: a pharmacologic and pathologic study. Anesthesiology 1986;64:43-53.
10. Lehman KA, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage 1992;3(suppl):8-16.
11. Schultheiss PJ, Morse BC, Baker WH. Evaluation of a transdermal fentanyl system in the dog. Lab Anim Sci 1995;54:75-81.
12. Payne R. Transdermal fentanyl: suggested recommendations for clinical use. J Pain Symptom Manage 1992;3(suppl): 40-44.
13. Kyles AE, Papich M, Hardie EM. Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 1996;57:715-719.
14. Scherk-Nixon M. A study of the use of a transdermal fentanyl patch in cats. J Am Anim Hasp Assoc 1996;32:19-24.
15. Michiels M, Hendriks R, Heykants J. A sensitive radioimmunoassay for fentanyl. Eur J Clin Pharmacol 1977;12:153-158.
16. Gibaldi M, Perrier D. One compartment model. In: Gibaldi M and Perrier D, eds. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc. 1982;1-43.
17. Zech DFJ, Grand SUA, Duaer HG. Transdermal fentanyl and initial dose finding with patient controlled analgesia in cancer pain. Pain 1992;50:293-301.
18. Gourlay GK, Mather LE. Post-operative pain management with TTS fentanyl: pharmacokinetics and pharmacodynamics. In: Lehman KA, Zech D, eds. Transdermal fentanyl. Berlin: Springer-Verlag Inc, 1991;119-140.
19. Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989;70:928-934.
20. Monteiro-Reviere NA, Bristol DG, Manning TO, et al. Interspecies and interregional analysis of comparative histologic thickness and laser-Doppler blood flow measurements at five cutaneous sites in nine species. J Invest Dermatol 1990;95: 582-586.
21. Murphy MR, Hug CC, McClain DA. Dose independent pharmacokinetics of fentanyl. Anesthesiology 1983;59:537-540.
22. Duragesic transdermal fentanyl delivery system (Package insert). Titusville, NJ: Jannsen Pharmaceuticals Inc, 1998.
23. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971;51:702-747.
24. Scheuplein RJ, Bronough RL. Percutaneous absorption. In: Goldsmith LA, ed. Biochemistry and physiology of the skin. New York: Oxford University Press, 1983;1255-1296.
25. Scott D. Feline dermatology. J Am Anim Hosp Assoc 1991;16:331-339.
26. Barry BW The lipid-protein partitioning theory of skin penetration enhancement. In: Bronough RL, Maibach HI, eds. Invitro percutaneous absorption. Boca Raton, Fla: CRC Press, 1991;165-185.
27. Webster RC, Maibach HI. Individual and regional variation with in-vitro and in-vivo percutaneous absorption. In: Bronough RL, Maibach HI, eds. In-vitro percutaneous absorption. Boca Raton, Fla: CRC Press, 1991;25-30.